Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059563) titled 'Burden of Illness Study among Patients with Narcolepsy or Idiopathic Hypersomnia in Japan' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Takeda Pharmaceutical Company Limited
Condition:
Condition - Narcolepsy, Idiopathic hypersomnia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Estimate total costs and EuroQol-5 Dimension (EQ-5D)-derived health utilities among patients with Narcolepsy type 1, Narcolepsy type 2, and Idiopathic hypersomnia summarized by disease severity levels measured by the Japanese version of the Epworth Sleepiness Scale.
Bas...